Article

Lung Cancer in the VA at a National Level

Publish date: September 25, 2019
Author(s):
Christina D. Williams, PhD, MPH
Drew Moghanaki, MD, MPH

 

Recommended Reading

Open Clinical Trials for Patients With Lung Cancers (FULL)
Federal Practitioner
Real-world data for immunotherapy-treated NSCLC found robust
Federal Practitioner
COPD adds complexity to shared decision making for LDCT lung cancer screening
Federal Practitioner
Bevacizumab or pemetrexed, but not both, efficacious for NSCLC maintenance
Federal Practitioner
Immune-related toxicities, hospitalization common with checkpoint inhibitor therapy
Federal Practitioner
Timely Diagnosis of Lung Cancer in a Dedicated VA Referral Unit with Endobronchial Ultrasound Capability (FULL)
Federal Practitioner
HIV drug may enhance efficacy of chemoradiation in locally advanced lung cancer
Federal Practitioner
Prior antibiotic use lowers checkpoint inhibitor response and survival
Federal Practitioner
Many institutions exceed recommended radiation doses during lung cancer screening
Federal Practitioner
Lung Cancer – Regional Snapshot Kansas City VA
Federal Practitioner